Niagen Bioscience, Inc. Common Stock NAGE Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Selling by Business | ||||||
| Analytical Reference Standards and Services segment | $284K-40.0% | $347K-30.2% | $390K-16.0% | $431K-0.9% | $473K+17.5% | |
| Consumer Products segment | $10.99M+14.7% | $10.77M+15.9% | $10.62M+21.6% | $10.1M+17.8% | $9.58M+12.5% | |
| Ingredients segment | $189K+112% | $144K+260% | $127K+535% | $80K+90.5% | $89K+128% | |
| Marketing by Business | ||||||
| Analytical Reference Standards and Services segment | $2K-33.3% | $2K-50.0% | $1K-84.6% | $0-100% | $3K-64.7% | |
| Consumer Products segment | $12.46M+40.0% | $11.49M+37.7% | $10.13M+31.1% | $9.35M+22.3% | $8.9M+20.1% | |
| Ingredients segment | $173K-16.8% | $102K-47.7% | $205K+166% | $203K+227% | $208K+1,633% | |
| Advertising by Business | ||||||
| Analytical Reference Standards and Services segment | $0— | $0— | $0— | $0— | $0— | |
| Consumer Products segment | $12.97M+11.9% | $12.66M+14.0% | $12.34M+19.4% | $11.92M+17.3% | $11.59M+13.8% | |
| Ingredients segment | $0— | $0— | $0— | $0— | $0— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Niagen Bioscience, Inc. Common Stock break its business down?
- Niagen Bioscience, Inc. Common Stock (NAGE) reports net sales by business across 5 parts — Analytical Reference Standards and Services segment, Consumer Products segment, Corporate and other, Ingredients segment and Pharmaceuticals segment. Each is extracted from the segment footnotes and tracked over time.
- Where does Niagen Bioscience, Inc. Common Stock's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Niagen Bioscience, Inc. Common Stock's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
